Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$22.33 - $29.92 $506,377 - $678,495
22,677 New
22,677 $506,000
Q1 2023

May 12, 2023

BUY
$20.58 - $27.89 $57,315 - $77,673
2,785 Added 2931.58%
2,880 $64,000
Q4 2022

Feb 13, 2023

BUY
$15.31 - $29.94 $1,454 - $2,844
95 New
95 $2,000
Q1 2022

May 13, 2022

SELL
$21.94 - $42.51 $6,647 - $12,880
-303 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$36.09 - $53.79 $10,935 - $16,298
303 New
303 $12,000
Q3 2021

Nov 12, 2021

SELL
$35.62 - $52.97 $122,425 - $182,057
-3,437 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$32.94 - $56.62 $113,214 - $194,602
3,437 New
3,437 $137,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.97B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.